Research Catalog

Guidance for industry : gene therapy clinical trials, observing subjects for delayed adverse events.

Title
Guidance for industry : gene therapy clinical trials, observing subjects for delayed adverse events.
Publication
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]

Available Online

https://purl.fdlp.gov/GPO/LPS112486

Details

Additional Authors
Center for Biologics Evaluation and Research (U.S.)
Description
i, 23 pages : digital, PDF file
Alternative Title
Gene therapy clinical trials, observing subjects for delayed adverse events
Subject
  • Gene therapy > United States
  • Clinical trials > Government policy > United States
Note
  • Title from PDF title page (viewed on May 12, 2009).
  • "November 2006".
Bibliography (note)
  • Includes bibliographical references (page 23).
System Details (note)
  • Mode of access: Internet at the FDA CBER web site. Address as of 5/12/09: http://www.fda.gov/cber/gdlns/gtclin.pdf ; current access is available via PURL.
Call Number
GPO Internet HE 20.4802:G 28/3
OCLC
marcive320816600
Title
Guidance for industry : gene therapy clinical trials, observing subjects for delayed adverse events.
Publisher
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]
Type of Content
text
Type of Medium
computer
Type of Carrier
online resource
System Details
Mode of access: Internet at the FDA CBER web site. Address as of 5/12/09: http://www.fda.gov/cber/gdlns/gtclin.pdf ; current access is available via PURL.
Bibliography
Includes bibliographical references (page 23).
Connect to:
https://purl.fdlp.gov/GPO/LPS112486
Added Author
Center for Biologics Evaluation and Research (U.S.)
Gpo Item No.
0499-T-02 (online)
Sudoc No.
HE 20.4802:G 28/3
View in Legacy Catalog